Tech Company Financing Transactions
Nautilus Neurosciences Funding Round
On 2/8/2010, Nautilus Neurosciences raised $14.5 million in Series A financing from Tailwind Capital Partners and private investors.
Transaction Overview
Company Name
Announced On
2/8/2010
Transaction Type
Venture Equity
Amount
$14,490,000
Round
Series A
Investors
Tailwind Capital Partners (Lead Investor)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
135 Routes 202/206
Bedminster, NJ 07921
USA
Bedminster, NJ 07921
USA
Phone
Email Address
Overview
Nautilus Neurosciences is a neurology-focused specialty pharmaceutical company committed to providing the healthcare community with relevant products and services that directly benefit those affected by neurological disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Maichle
Chief Financial Officer
Neil Milano
Browse more venture capital transactions:
Prev: 2/8/2010: Compliance11 venture capital transaction
Next: 2/8/2010: PatientSafe Solutions venture capital transaction
Share this article
About Database of VC Transactions
We report on every notable VC transaction. VC investment data records reported here are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs